An expert discusses how the treatment landscape for lower-risk MDS has evolved with multiple new options including luspatercept, imetelstat, and lenalidomide based on specific patient characteristics ...

Researchers are developing AI programmes to make doping detection more effective, faster, and cheaper. How do these systems ...

The global erythropoietin drugs market was valued at approximately USD 6.87 billion in 2022 and is projected to grow at a healthy growth rate of around 1.5% during the forecast period from 2023 to ...

Two positives, two sporting careers abruptly halted due to the use of prohibited substances, and two sanctions for crossing the red line. The ...

Inadequate hemodialysis was a major cause of erythropoietin resistance in pediatric patients. Investigators have identified several risk factors associated with erythropoietin (EPO) resistance in ...

Research reveals erythropoietin suppresses immune cells in liver cancer. Learn how blocking EPO reactivates immunity, leading to total tumor regression.

Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

Erythropoietin, aka EPO, is best known for its role in the Lance Armstrong cheating scandal. But EPO is also the star of another, darker tale.

Erythropoietin (EPO) is a 30.4 kDa glycoprotein comprised of one 165 amino acid residues chain with four glycosylation locations (Figure 1). The hormone is produced naturally in the kidneys ...

The Erythropoietin (EPO) drugs market is a vital segment of the pharmaceutical industry that focuses on the development and distribution of medications aimed at stimulating red blood cell production.